FurchgottR.F., ZawadzkiJ.V.The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature1980; 288: 373–6.
2.
PalmerR.M., FerrigeA.G., MoncadaS.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature1987; 327: 524–6.
3.
RapoportR.M., DrazninM.B., MuradF.Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature1983; 306: 174–6.
4.
BlochK.D., WolframJ.R., BrownD.M.Three members of the nitricoxide synthase II gene family (NOS2A, NOS2B, and NOS2C) colocalize to human chromosome 17. Genomics1995; 27: 526–30.
5.
MarsdenP.A., HengH.H., SchererS.W.Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem1993; 268: 17478–88.
6.
NadaudS., BonnardeauxA., LathropM., SoubrierF.Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun1994; 198: 1027–33.
7.
WhiteK.A., MariettaM.A.Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry1992; 31: 6627–31.
8.
StuehrD.J., GrossS.S., SakumaI., LeviR., NathanC.F.Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Expl Med1989; 169: 1011–20.
9.
CunhaF.Q., MoncadaS., LiewF.Y.Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun1992; 182: 1155–9
10.
LiewF.Y., MillottS., LiY., LelchukR., ChanW.L., ZiltenerH.Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis. Eur J Immunol1989; 19: 1227–32.
11.
HuangP.L., HuangZ., MashimoH., BlochK.D., MoskowitzM.A., BevanJ.A.Hypertension in mice lacking the gene for endothelial nitric oxide synthase [see comments]. Nature1995; 377: 239–42.
WilliamsD., VallanceP., SpencerJ., NeildG., ImmsF.Nitric oxide mediated dilatation in human pregnancy. Am J Physiol (in press)
14.
RadomskiM.W., PalmerR.M., MoncadaS.The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun1987; 148: 1482–9.
15.
ChowienczykP.J., WattsG.F., CockcroftJ.R., RitterJ.M.Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet1992; 340: 1430–2.
16.
CalverA., CollierJ., MoncadaS., VallanccP.Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypert1993; 10: 1025–31.
17.
CalverA., CollierJ., VallanceP.Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest1992; 90: 2548–54.
CandipanR.C., WangB.Y., BuitragoR., TsaoP.S., CookeJ.P.Regression or progression. Dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol1996; 16: 44–50.
20.
MacAllisterR.J., WhitleyG.S., VallanceP.Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int1994; 45: 737–42.
21.
IgnarroL.J., BushP.A., BugaG.M., WoodK.S., FukutoJ.M., RajferJ.Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun1990; 170: 843–50.
22.
WrightC.E., ReesD.D., MoncadaS.Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res1992; 26: 48–57.
23.
PetrosA., BennettD., VallanceP.Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet1991; 338: 1557–8.
24.
BalligandJ.L., KellyR.A., MarsdenP.A., SmithT.W., MichelT.Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA1993; 90: 347–51.
25.
LewisN.P., TsaoP.S., RickenbacherP.R., XueC., JohnsR.A., HaywoodG.A.Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation1996; 93: 720–9.
26.
GastonB., ReillyJ., DrazenJ.M., FacklerJ., RamdeyP., ArnelleD.Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA1993; 90: 10957–61.
27.
KharitonovS.A., YatesD., RobbinsR.A., Logan SinclairR., ShinebourneE.A., BarnesP.J.Increased nitric oxide in exhaled air of asthmatic patients. Lancet1994; 343: 133–5.
28.
MearinF., MourelleM., GuarnerF., SalasA., Riveros MorenoV., MoncadaS.Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest1993; 23: 724–8.
29.
HuangP.L., DawsonT.M., BredtD.S., SnyderS.H., FishmanM.C.Targeted disruption of the neuronal nitric oxide synthase gene. Cell1993; 75: 1273–86.
30.
VanderwindenJ.M., MaillcuxP., SchiffmannS.N., VanderhaeghenJ.J., De LaetM.H.Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis [published erratum appears in N Engl J Med1992; 327: 1252] N Engl J Med 1992;327: 511-15
31.
FerreiraS.H., MoncadaS., VanJ.R.Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature New Biol1971; 231: 237–9.
32.
GellerD.A., FreeswickP.D., NguyenD., NusslerA.K., Di SilvioM., ShapiroR.A.Differential induction of nitric oxide synthase in hepatocytes during endotoxemia and the acute-phase response. Arch Surg1994; 129: 165–71.